Apolipoprotein E polymorphism in Alagille syndrome and progressive familial intrahepatic cholestasis

Digestive Diseases and Sciences

Volumn 45, Issue 4, 2000, Pages 675-679

  Socha, Piotr ^a   Nowicka, G ^a   Jankowska, I ^a   Rujner, J ^a   Pawlowska J ^a   Socha, J ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Cholestasis; Hypercholesterolemia; Lipid metabolism; Lipoprotein

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; URSODEOXYCHOLIC ACID;

ADOLESCENT; ALAGILLE SYNDROME; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLSTONE FORMATION; GENE FREQUENCY; HUMAN; INTRAHEPATIC CHOLESTASIS; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; TREATMENT OUTCOME;

ADOLESCENT; ALAGILLE SYNDROME; APOLIPOPROTEINS E; BILIRUBIN; CHILD; CHILD, PRESCHOOL; CHOLAGOGUES AND CHOLERETICS; CHOLELITHIASIS; CHOLESTASIS, INTRAHEPATIC; CHOLESTEROL; FEMALE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; PRURITUS; RETROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID;

EID: 0034038246     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005475106198     Document Type: Article

References (26)

1. 1. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8:1-21, 1988
2. 2. Bertomeu A, Ros E, Zambon D, Vela M, Perez-Ayuso RM, Targarona E, Trias M, et al: Apolipoprotein E polymorphism and gallstones. Gastroenterology 111:1603-1610, 1996
3. 3. Van Erpecum KJ, Van Berge-Henegouwen GP, Eckhardt ERM, Portincasa P, Van de Heijning BJM, Dallinga-Thie GM, Groen AK: Cholesterol crystallization in human gallbladder bile: Relation to gallstone number, bile composition, and apolipoprotein E4 isoform. Hepatology 27:1508-1516, 1998
4. 4. Vuoristo M, Farkkila M, Gylling H, Karvonen A-L, Leino R, Lehtola J, Makinen J, Mattila J, Tilvis R, Miettinen TA: Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis. J Hepatology 27:136-142, 1997
5. 5. Davit-Spraul A, Pourci ML, Atger V, Cambillau M, Hadchouel M, Moatti N, Legrand A: Abnormal lipoprotein pattern in patients with Alagille syndrome depends on icterus severity. Gastroenterology 111:1023-1032, 1996
6. 6. Kroon PA, Powell EE: Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism. J Gastroenterol Hepatol 7:214-224, 1992
7. 7. Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O, Hadchouel O: Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 23:904-908, 1996
8. 8. De Vree JML, Jacquemin E, Sturm E, Cresteil D, Bosma PJ, Aten J, Deleuze JF, Desrochers M, Burdelski M, Bernard OP, Elferink RPJO, Hadchouel O: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 95:282-287, 1998
9. 9. Bull LN, Carlton VEH, Stricker NL, Baharloo S, De Young JA, Freimer NB, Magid MS, Kahn E, Markowitz J, DiCarlo FJ, McLoughlin L, Boyle JT, Dahms BB, Faught PR, Fitzgerald JF, Piccoli DA, Witzleben CL, O'Connell NC, Setchell KDR, Agostini RM, Jr, Kocoshis SA, Reyes J, Knisely AS: Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogenity. Hepatology 26:155-164, 1997
10. 10. Arnell H, Nemeth A, Anneren G, Dahl N: Progressive familial intrahepatic cholestasis (PFIC): Evidence for genetic heterogenity by exclusion of linkage to chromosome 18q21-q22. Hum Genet 100:378-381, 1997
11. 11. Oda T, Eklahloun AG, Pike BL, Okajima K, Krnatz ID, Genin A, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC: Mutations in the human Jagged 1 gene are responsible for Alagille syndrome. Nature Genet 16:235-242, 1997
12. 12. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, Trask BJ, Kuo WL, Cochran J, Costa T, Pierpont MEM, Rand EB, Piccoli DA, Hood L, Spinner NB: Alagille syndrome is caused by mutations in the human JAGGED1, which encodes a ligand for NOTCHI. Nature Genet 16:243-251, 1997
13. 13. McDowell FW, Wisdom BG, Trimble ER: Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin Chem 35:2070-2073, 1989
14. 14. Kłosiewicz-Latoszek L, Nowicka G, Paluszkiewicz J, Pachocka L, et al: Hypolipemic diet effect on lipoprotein profile in patients with hypercholesterolaemia and mixed hyperlipidaemia in relation to apolipoprotein E phenotype. Med Sci Monit 5:62-70, 1999
15. 15. Tiret L, Knijf P, Menzel HJ, Ehnholm C, Nicaud V, Hevekes LM for the EARS Group: Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. Arterioscler Thromb 14:1617-1624, 1994
16. 16. Whitington PF, Whitngton GL: Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 95:130-136, 1988
17. 17. Seymour M, Sabesin MD: Cholestatic iipoproteins - their pathogenesis and significance. Gastroenterology 83:704-709, 1982
18. 18. Fielding CJ, Frohlich J, Moser K, Fielding PE: Promotion of sterol efflux and net transport by apolipoprotein E in lecithin: cholesterol acyltransferase deficiency. Metabolism 31:1023-1028, 1982
19. 19. Mahley RW: Apolipoprotein E. Cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988
20. 20. Angelin B, Holmquist L, Leijd B, Einarsson K: Bile acid metabolism in familial dysbetalipoproteinemia: studies in subjects with the apolipoprotein E-2/2 phenotype. Eur J Clin Invest 20:143-149, 1990
21. 21. Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL: Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 18:134-142, 1994
22. 22. Rujner J, Pawlowska J, Socha J, Chipczyńska B, Chodurska E, Tomczak E, Wróblewska M: Alagille syndrome: Clinical and biochemical characteristic of 27 children. Hepatol Pol 1:35-42, 1994
23. 23. Jacquemin E, Hermans D, Myara A, Habes D, Debray D, Hadchouel M, Sokal EM, Bernard O: Ursodeoxycholic acid therapy in pediatic patients with progressive familial intrahepatoc cholestasis. Hepatology 25:519-523, 1997
24. 24. Socha J, Jankowska I, Pawłowska J, Socha P, Świa̧tkowska E: Application of ursodeoxycholic acid in children with cholestasis. Pediatr Pol Suppl 9:137-140, 1995
25. 25. Krawinkel MB, Santer R, Oldigs HD: Ursodeoxycholic acid: Effect on xanthomas in Alagille-Watson syndrome. J Pediatr Gastroenterol Nutr 19:476-478, 1994
26. 26. Gidding SS, Stone NJ, Bookstein LC, Laskarzewski PM, Stein EA: Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. J Pediatr 133:242-246, 1998